InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,482.87
(
0.09%
)
US TECH 100
19,304.80
(
0.47%
)
Dow Jones
39,164.06
(
0.09%
)
Brent Oil
85.54
(
0.15%
)
Bitcoin
61,904.70
(
0.48%
)
Post# of 252412
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

BTH

Send PM Follow Ignore
Followers 16
Posts 4145
Boards Moderated 1
Alias Born 06/11/2010

BTH

Re: mcbio post# 158397

Friday, 03/15/2013 8:36:32 PM

Friday, March 15, 2013 8:36:32 PM

Post# of 252412

4. ARQL has shifted to testing specifically for patient MET status at the time of therapy. (Implication seemed to be that this provides for a more accurate reading of patient MET status when tivantinib is delivered.)



That's the good news.

The bad news is that it took them 2-3 years and $100 million to figure this out.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up